Lapatinib US FDA Label
- Compound: N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
- Description: Lapatinib is an organofluorine compound, an organochlorine compound, a member of quinazolines and a member of furans. It has a role as an antineoplastic agent and a tyrosine kinase inhibitor. It is functionally related to a monofluorobenzene.
- Brand Name:
- Code(s): GW572016
- Approved:
- Kinase Class: RY
- Inhibitor Type: I ½B
- Literature (PubMed): 0
- Target(s): epidermal growth factor receptor , Erb-b2 receptor tyrosine kinase 2
- Disease(s): Her2-receptor positive breast cancer